Chronic obstructive pulmonary disease
Conditions
Interventions
Exposure group:The treatment is guided by the guidelines for the combination of Zhichuan Ling Oral Liquid
Non-exposure group:Guidelines guide treatment
Sponsors
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age: 40 to 75 years old (inclusive) gender not limited; (2) It meets the Western medical diagnostic criteria for COPD and is in a stable period; (3) Pulmonary function grade II to IV; (4) All the research subjects signed informed consent forms
Exclusion criteria
Exclusion criteria: (1) Those with severe primary and/or secondary respiratory diseases such as bronchial asthma and lung cancer; (2) Combined with other severe cardiovascular and cerebrovascular diseases malignant arrhythmias (including ventricular tachycardia atrial flutter uncontrolled rapid atrial fibrillation severe sinus tachycardia severe sick sinus node syndrome or third-degree atrioventricular block) glaucoma grade III or above benign prostatic hypertrophy urinary retention severe kidney diseases hematopoietic system diseases etc And mental patients (3) Those who are known to be allergic to this medicine or any other excipients (4) Those who do not meet the regulations for combined medication (5) Pregnant lactating women and women of childbearing age who have not adopted contraceptive plans.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The relief rate of cough symptoms in the second week after enrollment; | — |
Secondary
| Measure | Time frame |
|---|---|
| CAT score;mMRC dyspnea score;The hospitalization rate of patients in the second week of enrollment;Emergency visit rate;TCM syndrome score and individual symptom score;Pulmonary function; | — |
Countries
China
Contacts
Public ContactFENG JIHONG
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed